-
1
-
-
0028120906
-
Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
-
Antiplatelet Trialists' Collaboration
-
Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106.
-
(1994)
BMJ
, vol.308
, pp. 81-106
-
-
-
2
-
-
0037065502
-
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
-
Antithrombotic Trialists' Collaboration
-
Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86.
-
(2002)
BMJ
, vol.324
, pp. 71-86
-
-
-
3
-
-
0024746737
-
Predictive value of factors of the hemostatic system in screening procedures for coronary artery disease
-
van de Loo JC. Predictive value of factors of the hemostatic system in screening procedures for coronary artery disease. Ric Clin Lab 1989; 19: 333-8.
-
(1989)
Ric Clin Lab
, vol.19
, pp. 333-338
-
-
van de Loo, J.C.1
-
4
-
-
0026783457
-
The PLAT Study: Hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group
-
Cortellaro M, Boschetti C, Cofrancesco E, Zanussi C, Catalano M, de Gaetano G, Gabrielli L, Lombardi B, Specchia G, Tavazzi L. The PLAT Study: Hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group. Arterioscler Thromb. 1992; 12: 1063-70.
-
(1992)
Arterioscler Thromb
, vol.12
, pp. 1063-1070
-
-
Cortellaro, M.1
Boschetti, C.2
Cofrancesco, E.3
Zanussi, C.4
Catalano, M.5
de Gaetano, G.6
Gabrielli, L.7
Lombardi, B.8
Specchia, G.9
Tavazzi, L.10
-
5
-
-
0020326485
-
Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: A difficult link
-
de Gaetano G, Cerletti C, Bertele V. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: A difficult link. Lancet 1982; 2: 974-7.
-
(1982)
Lancet
, vol.2
, pp. 974-977
-
-
de Gaetano, G.1
Cerletti, C.2
Bertele, V.3
-
6
-
-
24944474901
-
Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis; Working Group on Aspirin Resistance. Aspirin resistance: Position paper of the Working Group on Aspirin Resistance
-
Michelson AD, Cattaneo M, Eikelboom JW, Gurbel P, Kottke-Marchant K, Kunicki TJ, Pulcinelli FM, Cerletti C, Rao AK. Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis; Working Group on Aspirin Resistance. Aspirin resistance: Position paper of the Working Group on Aspirin Resistance. J Thromb Haemost 2005; 3: 1309-11.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 1309-1311
-
-
Michelson, A.D.1
Cattaneo, M.2
Eikelboom, J.W.3
Gurbel, P.4
Kottke-Marchant, K.5
Kunicki, T.J.6
Pulcinelli, F.M.7
Cerletti, C.8
Rao, A.K.9
-
7
-
-
8344231455
-
Aspirin and clopidogrel: Efficacy, safety, and the issue of drug resistance
-
Cattaneo M. Aspirin and clopidogrel: Efficacy, safety, and the issue of drug resistance. Arterioscler Thromb Vasc Biol 2004; 24: 1980-7.
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, pp. 1980-1987
-
-
Cattaneo, M.1
-
8
-
-
29244442937
-
Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin
-
Pulcinelli FM, Riondino S, Celestini A, Pignatelli P, Trifiro E, Di Renzo L, Violi F. Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin. J Thromb Haemost 2005; 3: 2784-9.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 2784-2789
-
-
Pulcinelli, F.M.1
Riondino, S.2
Celestini, A.3
Pignatelli, P.4
Trifiro, E.5
Di Renzo, L.6
Violi, F.7
-
9
-
-
34247521816
-
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease
-
Maree AO, Fitzgerald DJ. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. Circulation 2007; 115: 2196-207.
-
(2007)
Circulation
, vol.115
, pp. 2196-2207
-
-
Maree, A.O.1
Fitzgerald, D.J.2
-
10
-
-
34047096264
-
Variability in individual responsiveness to clopidogrel: Clinical implications, management, and future perspectives
-
Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA, Costa MA. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol 2007; 49: 1505-16.
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 1505-1516
-
-
Angiolillo, D.J.1
Fernandez-Ortiz, A.2
Bernardo, E.3
Alfonso, F.4
Macaya, C.5
Bass, T.A.6
Costa, M.A.7
-
11
-
-
33846235920
-
Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review
-
Hovens MM, Snoep JD, Eikenboom JC, van der Bom JG, Mertens BJ, Huisman MV. Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review. Am Heart J 2007; 153: 175-81.
-
(2007)
Am Heart J
, vol.153
, pp. 175-181
-
-
Hovens, M.M.1
Snoep, J.D.2
Eikenboom, J.C.3
van der Bom, J.G.4
Mertens, B.J.5
Huisman, M.V.6
-
12
-
-
34548062503
-
Response variability to aspirin as assessed by a platelet function analyzing device in 5,700 subjects: A systematic review of 40 studies
-
Crescente M, Di Castelnuovo A, Iacoviello L, Vermylen J, Cerletti C, de Gaetano G. Response variability to aspirin as assessed by a platelet function analyzing device in 5,700 subjects: A systematic review of 40 studies. J Thromb Haemost 2007; 5 (Suppl. 1): P-S-309.
-
(2007)
J Thromb Haemost
, vol.5
, Issue.SUPPL. 1
-
-
Crescente, M.1
Di Castelnuovo, A.2
Iacoviello, L.3
Vermylen, J.4
Cerletti, C.5
de Gaetano, G.6
-
13
-
-
0016390072
-
Indomethacin and platelet aggregation in chronic glomerulonephritis: Existence of non-responders
-
de Gaetano G, Vermylen J, Donati MB, Dotremont G, Michielsen P. Indomethacin and platelet aggregation in chronic glomerulonephritis: existence of non-responders. Br Med J 1974; 2: 301-3.
-
(1974)
Br Med J
, vol.2
, pp. 301-303
-
-
de Gaetano, G.1
Vermylen, J.2
Donati, M.B.3
Dotremont, G.4
Michielsen, P.5
-
14
-
-
0019430713
-
Inhibition of thromboxane synthetase does not necessarily prevent platelet aggregation
-
Bertelé V, Cerletti C, Schieppati A, Di Minno G, de Gaetano G. Inhibition of thromboxane synthetase does not necessarily prevent platelet aggregation. Lancet 1981; 1: 1057-8.
-
(1981)
Lancet
, vol.1
, pp. 1057-1058
-
-
Bertelé, V.1
Cerletti, C.2
Schieppati, A.3
Di Minno, G.4
de Gaetano, G.5
-
15
-
-
0020639135
-
Human blood platelet behaviour after inhibition of thromboxane synthetase
-
Heptinstall S, Fox SC. Human blood platelet behaviour after inhibition of thromboxane synthetase. Br J Clin Pharmacol 1983; 15 (Suppl. 1): 31S-7S.
-
(1983)
Br J Clin Pharmacol
, vol.15
, Issue.SUPPL. 1
-
-
Heptinstall, S.1
Fox, S.C.2
-
16
-
-
0021252763
-
Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: Modulatory role of cyclooxygenase products
-
Bertelé V, Falanga A, Tomasiak M, Chiabrando C, Cerletti C, de Gaetano G. Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: Modulatory role of cyclooxygenase products. Blood 1984; 63: 1460-6.
-
(1984)
Blood
, vol.63
, pp. 1460-1466
-
-
Bertelé, V.1
Falanga, A.2
Tomasiak, M.3
Chiabrando, C.4
Cerletti, C.5
de Gaetano, G.6
-
17
-
-
0023800094
-
Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders
-
Gresele P, Blockmans D, Deckmyn H, Vermylen J. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders. J Pharmacol Exp Ther 1988; 246: 301-7.
-
(1988)
J Pharmacol Exp Ther
, vol.246
, pp. 301-307
-
-
Gresele, P.1
Blockmans, D.2
Deckmyn, H.3
Vermylen, J.4
-
18
-
-
0019466241
-
Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition
-
Dejana E, Cerletti C, De Castellarnau C, Livio M, Galletti F, Latini R, de Gaetano G. Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition. J Clin Invest 1981; 68: 1108-12.
-
(1981)
J Clin Invest
, vol.68
, pp. 1108-1112
-
-
Dejana, E.1
Cerletti, C.2
De Castellarnau, C.3
Livio, M.4
Galletti, F.5
Latini, R.6
de Gaetano, G.7
-
19
-
-
0020049595
-
Non-steroidal anti-inflammatory drugs react with two sites on platelet cyclo-oxygenase. Evidence from 'in vivo' drug interaction studies in rats
-
Cerletti C, Livio M, de Gaetano G. Non-steroidal anti-inflammatory drugs react with two sites on platelet cyclo-oxygenase. Evidence from 'in vivo' drug interaction studies in rats. Biochim Biophys Acta 1982; 714: 122-8.
-
(1982)
Biochim Biophys Acta
, vol.714
, pp. 122-128
-
-
Cerletti, C.1
Livio, M.2
de Gaetano, G.3
-
20
-
-
0021352475
-
Structural requirements for preventing the aspirin- and the arachidonate-induced inactivation of platelet cyclo-oxygenase: Additional evidence for distinct enzymatic sites
-
Rotilio D, Joseph D, Hatmi M, Vargaftig BB. Structural requirements for preventing the aspirin- and the arachidonate-induced inactivation of platelet cyclo-oxygenase: Additional evidence for distinct enzymatic sites. Eur J Pharmacol 1984; 97: 197-208.
-
(1984)
Eur J Pharmacol
, vol.97
, pp. 197-208
-
-
Rotilio, D.1
Joseph, D.2
Hatmi, M.3
Vargaftig, B.B.4
-
21
-
-
0022371180
-
Pharmacology of platelet inhibition in humans: Implications of the salicylate-aspirin interaction
-
de Gaetano G, Cerletti C, Dejana E, Latini R. Pharmacology of platelet inhibition in humans: Implications of the salicylate-aspirin interaction. Circulation 1985; 72: 1185-93.
-
(1985)
Circulation
, vol.72
, pp. 1185-1193
-
-
de Gaetano, G.1
Cerletti, C.2
Dejana, E.3
Latini, R.4
-
22
-
-
0020360347
-
Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity
-
Livio M, Del Maschio A, Cerletti C, de Gaetano G. Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity. Prostaglandins 1982; 23: 787-96.
-
(1982)
Prostaglandins
, vol.23
, pp. 787-796
-
-
Livio, M.1
Del Maschio, A.2
Cerletti, C.3
de Gaetano, G.4
-
23
-
-
0020558909
-
Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin
-
Rao GH, Johnson GG, Reddy KR, White JG. Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin. Arteriosclerosis 1983; 3: 383-8.
-
(1983)
Arteriosclerosis
, vol.3
, pp. 383-388
-
-
Rao, G.H.1
Johnson, G.G.2
Reddy, K.R.3
White, J.G.4
-
24
-
-
0029056992
-
The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase
-
Loll PJ, Picot D, Garavito RM. The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nat Struct Biol 1995; 2: 637-43.
-
(1995)
Nat Struct Biol
, vol.2
, pp. 637-643
-
-
Loll, P.J.1
Picot, D.2
Garavito, R.M.3
-
25
-
-
0035924765
-
Cyclooxygenase inhibitors and the antiplatelet effects of aspirin
-
Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, Tournier B, Vyas SN, FitzGerald GA. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 2001; 345: 1809-17.
-
(2001)
N Engl J Med
, vol.345
, pp. 1809-1817
-
-
Catella-Lawson, F.1
Reilly, M.P.2
Kapoor, S.C.3
Cucchiara, A.J.4
DeMarco, S.5
Tournier, B.6
Vyas, S.N.7
FitzGerald, G.A.8
-
26
-
-
0037442182
-
Effect of ibuprofen on cardioprotective effect of aspirin
-
MacDonald TM, Wei L. Effect of ibuprofen on cardioprotective effect of aspirin. Lancet 2003; 361: 573-4.
-
(2003)
Lancet
, vol.361
, pp. 573-574
-
-
MacDonald, T.M.1
Wei, L.2
-
27
-
-
0141851094
-
Aspirin resistance: Definition, mechanisms and clinical read-outs
-
Patrono C. Aspirin resistance: Definition, mechanisms and clinical read-outs. J Thromb Haemost 2003; 1: 1710-3.
-
(2003)
J Thromb Haemost
, vol.1
, pp. 1710-1713
-
-
Patrono, C.1
-
28
-
-
0141627621
-
Aspirin resistance: A revival of platelet aggregation tests?
-
de Gaetano G, Cerletti C. Aspirin resistance: A revival of platelet aggregation tests? J Thromb Haemost 2003; 1: 2048-50.
-
(2003)
J Thromb Haemost
, vol.1
, pp. 2048-2050
-
-
de Gaetano, G.1
Cerletti, C.2
-
29
-
-
17144396926
-
Platelet function testing in cardiovascular diseases
-
Michelson AD. Platelet function testing in cardiovascular diseases. Circulation 2004; 110: E489-93.
-
(2004)
Circulation
, vol.110
-
-
Michelson, A.D.1
-
30
-
-
0346367328
-
Aggregation of blood platelets by adenosine diphosphate and its reversal
-
Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-9.
-
(1962)
Nature
, vol.194
, pp. 927-929
-
-
Born, G.V.R.1
-
31
-
-
0001332609
-
Platelet aggregation. Part II: Some results of a new method
-
O'Brien JR. Platelet aggregation. Part II: Some results of a new method. J Clin Pathol 1962; 194: 452-5.
-
(1962)
J Clin Pathol
, vol.194
, pp. 452-455
-
-
O'Brien, J.R.1
-
33
-
-
34548075511
-
Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients
-
Paniccia R, Antonucci E, Gori AM, Marcucci R, Giglioli C, Antoniucci D, Gensini GF, Abbate R, Prisco D. Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients. J Thromb Haemost 2007; 5: 1839-47.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 1839-1847
-
-
Paniccia, R.1
Antonucci, E.2
Gori, A.M.3
Marcucci, R.4
Giglioli, C.5
Antoniucci, D.6
Gensini, G.F.7
Abbate, R.8
Prisco, D.9
-
34
-
-
15944383861
-
Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases
-
Aleil B, Ravanat C, Cazenave JP, Rochoux G, Heitz A, Gachet C. Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost 2005; 3: 85-92.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 85-92
-
-
Aleil, B.1
Ravanat, C.2
Cazenave, J.P.3
Rochoux, G.4
Heitz, A.5
Gachet, C.6
-
35
-
-
33845366186
-
Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor
-
Pampuch A, Cerletti C, de Gaetano G. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor. Thromb Haemost 2006; 96: 767-73.
-
(2006)
Thromb Haemost
, vol.96
, pp. 767-773
-
-
Pampuch, A.1
Cerletti, C.2
de Gaetano, G.3
-
36
-
-
33845528397
-
Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance'
-
Michelson AD, Linden MD, Furman MI, Li Y, Barnard MR, Fox ML, Lau WC, McLaughlin TJ, Frelinger AL. Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance'. J Thromb Haemost 2007; 5: 75-81.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 75-81
-
-
Michelson, A.D.1
Linden, M.D.2
Furman, M.I.3
Li, Y.4
Barnard, M.R.5
Fox, M.L.6
Lau, W.C.7
McLaughlin, T.J.8
Frelinger, A.L.9
-
37
-
-
0038649988
-
Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity
-
Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003; 107: 2908-13.
-
(2003)
Circulation
, vol.107
, pp. 2908-2913
-
-
Gurbel, P.A.1
Bliden, K.P.2
Hiatt, B.L.3
O'Connor, C.M.4
-
38
-
-
9644281093
-
The difference between clopidogrel responsiveness and posttreatment platelet reactivity
-
Samara WM, Bliden KP, Tantry US, Gurbel PA. The difference between clopidogrel responsiveness and posttreatment platelet reactivity. Thromb Res 2005; 115: 89-94.
-
(2005)
Thromb Res
, vol.115
, pp. 89-94
-
-
Samara, W.M.1
Bliden, K.P.2
Tantry, U.S.3
Gurbel, P.A.4
-
39
-
-
1642289998
-
The epidemiological night where all patients are black: Will pharmacogenetics shed some light?
-
de Gaetano G, Cerletti C, Iacoviello L, Donati MB. The epidemiological night where all patients are black: Will pharmacogenetics shed some light? Thromb Res 2003; 112: 273-4.
-
(2003)
Thromb Res
, vol.112
, pp. 273-274
-
-
de Gaetano, G.1
Cerletti, C.2
Iacoviello, L.3
Donati, M.B.4
-
40
-
-
9844224482
-
Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty
-
Mueller MR, Salat A, Stangl P, Murabito M, Pulaki S, Boehm D, Koppensteiner R, Ergun E, Mittlboeck M, Schreiner W, Losert U, Wolner E. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost 1997; 78: 1003-7.
-
(1997)
Thromb Haemost
, vol.78
, pp. 1003-1007
-
-
Mueller, M.R.1
Salat, A.2
Stangl, P.3
Murabito, M.4
Pulaki, S.5
Boehm, D.6
Koppensteiner, R.7
Ergun, E.8
Mittlboeck, M.9
Schreiner, W.10
Losert, U.11
Wolner, E.12
-
41
-
-
0037046196
-
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
-
Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 2002; 105: 1650-5.
-
(2002)
Circulation
, vol.105
, pp. 1650-1655
-
-
Eikelboom, J.W.1
Hirsh, J.2
Weitz, J.I.3
Johnston, M.4
Yi, Q.5
Yusuf, S.6
-
42
-
-
0037454168
-
A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease
-
Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003; 41: 961-5.
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 961-965
-
-
Gum, P.A.1
Kottke-Marchant, K.2
Welsh, P.A.3
White, J.4
Topol, E.J.5
-
43
-
-
8344221349
-
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction
-
Matetzky S, Shenkman B, Guetta V, Shechter M, Bienart R, Goldenberg I, Novikov I, Pres H, Savion N, Varon D, Hod H. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004; 109: 3171-5.
-
(2004)
Circulation
, vol.109
, pp. 3171-3175
-
-
Matetzky, S.1
Shenkman, B.2
Guetta, V.3
Shechter, M.4
Bienart, R.5
Goldenberg, I.6
Novikov, I.7
Pres, H.8
Savion, N.9
Varon, D.10
Hod, H.11
|